Tirzepatide came off the FDAs official drug shortage list in December 2024, and semaglutide followed in February 2025, eliminating the legal pathway that allowed compounding pharmacies to produce copies of the drugs
Significant improvements were observed in: Blood pressure LDL cholesterol and triglycerides Uric acid Liver enzymes Insulin sensitivity Importantly, no increased cardiovascular risks were noted
doi: 10.1016/S0140-6736(02)11911-8 267 LiuQK
4, 5, 6, 7 GIP is secreted from K cells in the proximal small bowel and binds to GIP receptors expressed by pancreatic islet cells, as well as to receptors in adipose tissue and the brain
Find out if youre eligible for weight loss medication What is your weight loss goal
"(It's) definitely around in my family, and I really wanted to just look deeper," she explains